Assistive & surgical robotics

In one line

Two very different families share a word. Surgical robots are precision instruments a surgeon drives. Assistive robots help a person live — and reach vastly more people, for vastly less money, with vastly less attention.

Surgical robotics: what it actually is

A modern surgical robot is a teleoperator. The surgeon sits at a console, their hand motions are scaled down and tremor-filtered, and articulated instruments reproduce them inside the patient. As the fundamentals entry explains, the real advance was restoring degrees of freedom that laparoscopy's fixed ports removed — a wrist inside the body.

Genuine benefits, and they're real: better ergonomics for the surgeon (which matters more than it sounds — surgeons injure themselves), tremor filtration, 3D vision, and access in confined spaces. It has been adopted heavily in prostatectomy and gynaecological surgery.

The evidence, honestly

This is where a knowledge base earns its keep, because the marketing and the literature don't agree.

Across many procedures, robot-assisted surgery shows outcomes broadly comparable to laparoscopic surgery — sometimes modestly better on blood loss or length of stay, frequently no different on the outcomes patients care about most, and reliably longer in theatre time and higher in cost. Cochrane reviews across several indications land repeatedly on "comparable, more expensive, evidence often low-certainty."

That is not an argument against surgical robots. It's an argument against the sentence hospitals actually use — "we have the robot, therefore we are advanced." A robot is a capital purchase with a marketing function attached, and in a market where patients choose hospitals, the purchase is sometimes competitive rather than clinical.

For an Indian health system deciding between a surgical robot and, say, a functioning imaging service or more nurses, the opportunity cost is the entire question — and it is rarely the one asked.

Assistive robotics: the bigger story

Meanwhile: over 2.5 billion people need at least one assistive product, and WHO estimates that nearly a billion of them lack access. Prosthetics, powered wheelchairs, exoskeletons for gait rehabilitation, feeding aids, communication devices.

The asymmetry is stark. A surgical robot serves a few hundred patients a year at one hospital and gets a press release. A well-designed, affordable prosthetic limb changes a life, and could change millions — and gets almost no attention from the technology press.

The hard problems in assistive robotics are also unglamorous and unsolved: cost, repairability, local supply chains, and fit. A device that needs a specialist to service it is useless in a district where there is none. The most valuable innovation in this field is frequently a cheaper material or a simpler mechanism, not a smarter algorithm.

There's a real health-equity point here: assistive technology is where robotics could do the most good for the most people, and it is where the least capital flows — because the people who need it cannot pay.

Where informatics sits

Both families generate data worth capturing, and mostly nobody does:

• Surgical: instrument kinematics, timings, forces, video — an objective record of how the operation was performed. Surgical data science is built on this, and consent and provenance are unresolved.
• Assistive: usage telemetry that reveals whether the device is actually being used or is in a cupboard — the single most useful and least collected fact in the field. Abandonment rates for assistive devices are high, and nobody knows precisely why, because nobody measured.

If you want a research question in this space with real impact: why do people stop using the device they were given? That's an informatics problem, not a robotics one.